GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Discussion] we are measuring 503A at the wrong time and calling it noise — 27 comments in the full submission. View in context.
411
c/compounding·submitted 7 months ago by u/runa_grimaldi

[Discussion] we are measuring 503A at the wrong time and calling it noise

Discussionbranch of 9 comments

Trying to settle this properly because the thread from last year went in circles. The claim: API source matters. The counter-claim: it is measurement error. Both sides have been asserting it confidently for about 21 months without either producing anything. What would actually settle it is 31 people measuring the…

Read the full submission and all 27 comments →

This branch

9 comments, started 7 months ago
u/teodor_duarte94 points·7 months ago

This is correct. The shortage list does expire and the rules change.

replysharereportpermalink
u/chidi_demir-26 points·7 months ago

Did they tell you their API source or dodge the question?

replysharereportpermalink
u/eu_apotheke_a1 point·7 months ago

the the UK situation is different from the US, different regulations

replysharereportpermalink
u/runa_grimaldiOP1 point·7 months ago

regulatory claims need a citation to the actual rule, not interpretation

replysharereportpermalink
u/emil_okwuosa1 point·7 months ago

state board rules differ, say which state

replysharereportpermalink
[removed]1 point·7 months ago

[removed by moderator]

replysharereportpermalink
u/burned_once_twice1 point·7 months ago

regulatory claims need a citation to the actual rule, not interpretation

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

replysharereportpermalink
u/runa_grimaldiOP1 point·7 months ago

Slight fix: the number was 95.1, not 94.2. Decimal point, but a fairly consequential one.

replysharereportpermalink
u/honest_syringe56 points·7 months ago

Sceptical. If this were true we would see it reflected in the data and we do not.

replysharereportpermalink

← back to the whole thread

About c/compounding

Compounded GLP-1s as a supply route: the 503A/503B distinction, the shortage-list mechanics that made compounding legal and then didn't, state board rules, telehealth prescriber models, and what a compounding pharmacy will and will not tell you about its API source.

53kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/compounding rules
  1. Regulatory claims need a citation to the actual rule, notice or docket.
  2. No pharmacy referral codes. Naming a pharmacy is fine; recruiting for it is not.
  3. API source questions are on-topic and pharmacies dodging them is newsworthy.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.